235 related articles for article (PubMed ID: 24725236)
1. Therapy for hepatitis C--the costs of success.
Hoofnagle JH; Sherker AH
N Engl J Med; 2014 Apr; 370(16):1552-3. PubMed ID: 24725236
[No Abstract] [Full Text] [Related]
2. A combination of ledipasvir and sofosbuvir (Harvoni) for hepatitis C.
Med Lett Drugs Ther; 2014 Nov; 56(1455):111-2. PubMed ID: 25372848
[No Abstract] [Full Text] [Related]
3. Eight Weeks Treatment With Sofosbuvir/Ledipasvir in a 4-year-old Child With Chronic Hepatitis C Virus Genotype 1 Infection.
Graf Einsiedel H; Christiansen H; Wiegand J
Pediatr Infect Dis J; 2016 Dec; 35(12):1373. PubMed ID: 27832030
[No Abstract] [Full Text] [Related]
4. Hepatitis C and HIV co-infection: closing the gaps.
Graham CS
JAMA; 2015 Mar 24-31; 313(12):1217-8. PubMed ID: 25705993
[No Abstract] [Full Text] [Related]
5. Are we hopefully very close to the end of HCV?
Tahan V
Turk J Gastroenterol; 2014 Apr; 25(2):230-1. PubMed ID: 25003693
[No Abstract] [Full Text] [Related]
6. Shorter treatments for hepatitis C: another step forward?
Foster GR
Lancet; 2015 Mar; 385(9973):1054-5. PubMed ID: 25591504
[No Abstract] [Full Text] [Related]
7. Hepatitis C Virus Infection in ESKD Patients.
Ladino M; Roth D
Clin J Am Soc Nephrol; 2018 Nov; 13(11):1735-1737. PubMed ID: 30065068
[No Abstract] [Full Text] [Related]
8. Sofosbuvir/ledipasvir as treatment of hepatitis C virus genotype 5 infection: Two case reports.
Chamorro-de-Vega E; Gimenez-Manzorro A; Sanjurjo M;
Med Clin (Barc); 2018 Jul; 151(2):85-86. PubMed ID: 29295791
[No Abstract] [Full Text] [Related]
9. Drug-Drug Interactions in Patients Co-infected With HCV and HIV.
Nozaki Y; Yanase M; Masaki N
JAMA; 2015 Jul; 314(2):186. PubMed ID: 26172899
[No Abstract] [Full Text] [Related]
10. Drug-Drug Interactions in Patients Co-infected With HCV and HIV--Reply.
Osinusi A; Townsend K; Kottilil S
JAMA; 2015 Jul; 314(2):186-7. PubMed ID: 26172900
[No Abstract] [Full Text] [Related]
11. Two Antiviral Drugs Approved For Adolescents With HCV.
Aschenbrenner DS
Am J Nurs; 2017 Aug; 117(8):22. PubMed ID: 28749879
[No Abstract] [Full Text] [Related]
12. Treatment of hepatitis C with 8 weeks of ledipasvir/sofosbuvir: Highly effective in a predominantly black male patient population.
Tang L; Parker A; Flores Y; Dellario M; Dickson C; Amoroso A; Kottilil S; Wilson E
J Viral Hepat; 2018 Feb; 25(2):205-208. PubMed ID: 28984059
[No Abstract] [Full Text] [Related]
13. Viral hepatitis: new hepatitis C therapies-a medical pick and mix.
Ray K
Nat Rev Gastroenterol Hepatol; 2014 Jun; 11(6):329. PubMed ID: 24776807
[No Abstract] [Full Text] [Related]
14. [Interferon free recovery for almost all patients].
Einecke D
MMW Fortschr Med; 2015 Mar; 157(4):71. PubMed ID: 25743991
[No Abstract] [Full Text] [Related]
15. Anti-HCV for porphyria cutanea tarda.
Abdelmaksoud A
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28133909
[No Abstract] [Full Text] [Related]
16. Experience and Outcomes of Hepatitis C Treatment in a Cohort of Homeless and Marginally Housed Adults.
Barocas JA; Beiser M; León C; Gaeta JM; O'Connell JJ; Linas BP
JAMA Intern Med; 2017 Jun; 177(6):880-882. PubMed ID: 28395004
[No Abstract] [Full Text] [Related]
17. Assessing a broader user base for new HCV drug.
Sekkides O
Lancet Infect Dis; 2015 Apr; 15(4):383. PubMed ID: 25809898
[No Abstract] [Full Text] [Related]
18. Four weeks of ledipasvir/sofosbuvir and ribavirin with or without pegylated interferon for chronic hepatitis C in non-cirrhotic people who inject drugs. A randomized trial.
Øvrehus ALH; Krarup H; Birkemose I; Holm DK; Mössner B; Ernst A; Christensen PB
J Hepatol; 2018 Apr; 68(4):840-842. PubMed ID: 29223370
[No Abstract] [Full Text] [Related]
19. Cost-Effectiveness Modelling of Sofosbuvir-Containing Regimens for Chronic Genotype 5 Hepatitis C Virus Infection in South Africa.
Fraser I; Burger J; Lubbe M; Dranitsaris G; Sonderup M; Stander T
Pharmacoeconomics; 2016 Apr; 34(4):403-17. PubMed ID: 26666639
[TBL] [Abstract][Full Text] [Related]
20. Remission of Psoriasis After Treatment of Chronic Hepatitis C Virus Infection With Direct-Acting Antivirals.
Enomoto M; Tateishi C; Tsuruta D; Tamori A; Kawada N
Ann Intern Med; 2018 May; 168(9):678-680. PubMed ID: 29335738
[No Abstract] [Full Text] [Related]
[Next] [New Search]
